Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Pfizer’s COVID pill reportedly offered no measurable benefit for adults 40 to 65, according to a study published on Wednesday.

The Israeli study was conducted among 109,000 patients who were 40 years old or older.

READ MORE
 

Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Sec of State Orders LGBT Flags Flown at U.S. Embassies

The full range of LGBTQ rights haven't been openly embraced…
Read more

Film Tells Children There Are ‘over 100’ Genders

BBC has created a film aimed at young children explaining…
Read more

Xi Takes Victory Lap at Davos

XI Jinping celebrates in victory a year later after the global…
Read more